Abstract
Streptococcus pneumoniae isolates (n = 262) were recovered from adult patients with community-acquired pneumonia. Erythromycin-resistance levels increased from 9% (1997-1998) to 16% (2000-2002). Sampling for resistance mechanisms prevalent within 19 erythromycin-resistant S. pneumoniae showed mef(E) in 13/19 isolates while 4/19 carried the erm(B) gene (3/19 cMLS(B) and 1/19 iMLS(B) phenotype). MIC ranges for erythromycin and clindamycin were 0.5-16 mg/l and <0.008-0.063 mg/l for the M phenotype, 128-512 mg/l and 128-256 mg/l for the cMLS(B) phenotype, and 4 and <0.008 mg/l for the iMLS(B) phenotype. This is the first report studying the prevalence of macrolide resistance determinants in S. pneumoniae in our country.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Anti-Bacterial Agents / pharmacology*
-
Argentina
-
Bacterial Proteins / genetics
-
Clindamycin / pharmacology
-
Community-Acquired Infections / microbiology*
-
Drug Resistance, Bacterial / genetics*
-
Erythromycin / pharmacology
-
Genes, Bacterial
-
Genotype
-
Hospitals, Teaching
-
Humans
-
Macrolides / pharmacology*
-
Membrane Proteins / genetics
-
Methyltransferases / genetics
-
Microbial Sensitivity Tests
-
Pneumonia, Pneumococcal / microbiology*
-
Streptococcus pneumoniae / drug effects*
-
Streptococcus pneumoniae / genetics
-
Streptococcus pneumoniae / isolation & purification
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Macrolides
-
MefE protein, Streptococcus pneumoniae
-
Membrane Proteins
-
Clindamycin
-
Erythromycin
-
ErmTR protein, bacteria
-
Methyltransferases